CABASMALL

Cabaletta Bio, Inc.

HealthcareBiotechnology
$4.00
$0.00(+7.24%)
52W$1.11
$4.23
Updated May 7, 12:00 AM
RSI61
RS Rating79/99
Beta2.54
Volatility113%
F-Score1/9
Mkt Cap$409M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Cabaletta Bio, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 79), indicating performance broadly in line with the market. Earnings growth of 37% provides fundamental context to the price action. However, price is extended 27% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
79
out of 99
Average
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
2.54
vs S&P 500
HIGH BETA
52W Position
93%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.14
50 SMA > 100 SMA$2.83
100 SMA > 150 SMA$2.73
150 SMA > 200 SMA$2.48

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.29+21.68%ABOVE
50 SMA$3.14+27.27%ABOVE
100 SMA$2.83+41.37%ABOVE
150 SMA$2.73+46.56%ABOVE
200 SMA$2.48+60.98%ABOVE

Price Performance

1D+7.2%
1W+33.8%
1M+30.3%
3M+63.9%
6M+56.9%
YTD+81.0%
1Y+244.8%
3Y-30.1%
52-Week Trading Range93% from low
$4.00
52W Low$1.11
52W High$4.23

Technical Indicators

RSI (14)BULLISH
60.8
305070
VCP ScoreCOOL
2/10
Base depth: 44.5%

Risk Profile

Beta
2.54
52W Vol
113%
ATR
$0.20
Max DD (1Y)
-46%

Volume Analysis

Today
5.26M
50D Avg
2.76M
Vol Ratio
1.91x
Liquidity
MODERATE

Earnings Momentum

Q1'25-43%
$-0.73
Q2'25-30%
$-0.73
Q3'25+29%
$-0.44
Q4'25+37%
$-0.41
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+1.28%

Stock Price CAGR

10 Years:-8.76%
5 Years:-16.01%
3 Years:-30.08%
1 Year:+244.83%

Return on Equity

10Y Avg:-52.6%
5Y Avg:-62.9%
3Y Avg:-75.4%
Last Year:-121.7%

Key Metrics

Market Cap$409M
Gross Margin
Net Margin
Piotroski F-Score1/9

Frequently Asked Questions

Is CABA in an uptrend right now?

CABA has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, CABA is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is CABA overbought or oversold?

CABA's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.

Is CABA outperforming the market?

CABA has a Relative Strength (RS) Rating of 79 out of 99. CABA is performing about average compared to the market.

Where is CABA in its 52-week range?

CABA is trading at $4.00, which is 95% of its 52-week high ($4.23) and 93% above its 52-week low ($1.11).

How volatile is CABA?

CABA has a Beta of 2.54 and 52-week volatility of 113%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.